The buildup of nonionic surfactants in the aqueous environment produces niosomes. The
usage of niosomes is becoming increasingly frequent due to their sustainability, low cost of …

Nanocarrier based formulations are increasing due to significant advantages over traditional
formulations. They have shown potential in improvement if drug's physicochemical and …

Topical drug delivery is preferable route over systemic delivery in case of Cutaneous
leishmaniasis (CL). Among the available agents, amphotericin B (AmB) and pentamidine …

The goal was to scrutinize niosomes as potential carriers for enhanced efficacy of
norfloxacin against Toxoplasma gondii RH strain. This was assessed in vitro and in vivo …

Nanoniosome-based drug codelivery systems have become popular therapeutic
instruments, demonstrating tremendous promise in cancer therapy, infection treatment, and …

Due to the limitations of current chemotherapy for the treatment of leishmaniasis, there is an
urgent requirement to search for new anti-leishmanial compounds and nano-drug delivery …

Leishmaniasis is one of the biggest concerns of the World Health Organization (WHO) due
to its severe side effects, the emergence of resistance, and secondary bacterial infections; …

Nanotechnology has been used for drug encapsulation with the development of more
effective and less toxic nanomedicines. Some currently used antimicrobials present …

Parasitic infections are prime causes of morbidity and mortality worldwide. Significant
progress has been made to cure these infections, such as discovering antiparasitic drugs …

Introduction. Leishmaniasis is a neglected tropical and subtropical disease caused by over
20 protozoan species. Hypothesis. Treatment of this complex disease with traditional …